CHAIRMAN OF THE BOARD OF DIRECTORS
“Zymergen is pioneering technology that shifts society in an exciting new direction.”
Jay served as CEO of Illumina for 17 years before transitioning to his role as chairman. As CEO, he led the company in cutting the cost of sequencing the human genome from $100 million to less than $1,000. He holds a BSc and MSc (Hons) from Stanford University, as well as a BA from Claremont McKenna College.